 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
WWII Discovery May Counter Bioterrorists
Fort Wayne - Mar 03, 2003 A compound developed by British scientists early in World War II as a treatment against chemical weapons has value against today's threat of bioterrorism, according to Indiana University School of Medicine researchers at Indiana University-Purdue University Fort Wayne. Researchers studying British Anti-Lewisite provide an overview of its historical uses, development and clinical implications today of the heavy metal chelating agent, detailed in the March issue of the Annals of Emergency Medicine. BAL is a medical therapy to remove metal poisonings from the body. "BAL was secretly developed more than six decades ago by biochemists at Oxford University and is still stocked in many hospital pharmacies and used occasionally by emergency physicians," says article co-author Joel A. Vilensky, Ph.D., professor of anatomy at the School's Fort Wayne Center for Medical Education. Kent L. Redman, Ph.D., associate professor of biochemistry and molecular biology, co-authored the study with Dr. Vilensky. "The possible threat of terrorism gives this World War II discovery renewed significance among emergency physicians because it is a treatment for Lewisite, a chemical warfare agent that produces immediate pain and blistering on contact and can cause blindness if it gets into the eyes," Dr. Vilensky notes. "Lewisite is a threat because it is easy for any country to manufacture with simple pesticide-manufacturing technology." Iraq is believed to have used Lewisite in its earlier war with Iran. Developed for use during World War I, Lewisite is an arsenic-based liquid chemical compound that, similar to mustard, is easily vaporized into a poison gas and is capable of penetrating ordinary clothing and rubber. When inhaled in high concentrations, it may be fatal in as few as 10 minutes. Fear of German use of Lewisite led British scientists at the beginning of World War II to develop an antidote, 2,3-dimercaptopropanol, which came to be known as BAL. The treatment is capable of removing heavy metals such as arsenic, copper, mercury and lead from the human body. After the war, BAL was put to clinical use by becoming the first successful treatment for Wilson's disease, a genetic disorder that causes the body to retain copper. If not treated, Wilson's disease can cause severe brain damage, liver failure, and death. Today, BAL is one recommended treatment for children with very high blood lead levels in conjunction with other agents, the IU School of Medicine researchers noted in their article. "Little did those Oxford biochemists working on the antidote to a greatly feared chemical warfare agent realize that BAL would still be needed 60 years later for heavy metal poisoning," Dr. Redman notes. "In the process, BAL helped change clinical medicine and perhaps altered the course of World War II by reducing the fear of Lewisite's use on the battlefield." Community Email This Article Comment On This Article Related Links Indiana University SpaceDaily Search SpaceDaily Subscribe To SpaceDaily Express The Long War - Doctrine and Application
Team Of ORNL Agents Working To Keep People Safe
Oak Ridge TN (SPX) Jun 17, 2004Thousands of special agents created at the Department of Energy's Oak Ridge National Laboratory are on missions 24 hours a day as they work to uncover threats to national security. These agents, which are actually intelligent software programs, scan the Internet, satellite images, hundreds of newspapers and electronic databases worldwide as they search for anything that even hints at a plot. |
|
|
| The content herein, unless otherwise known to be public domain, are Copyright 1995-2006 - SpaceDaily.AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA PortalReports are copyright European Space Agency. All NASA sourced material is public domain. Additionalcopyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement |
